Shilpa Pharma proudly delivers world-class CDMO services to Germany, supporting pharmaceutical and biotech innovators with high-quality, compliant, and scalable manufacturing solutions. As a globally trusted contract development and manufacturing organization, we combine European-quality standards, cutting-edge technology, and deep scientific expertise to help German companies accelerate their pipeline from development to commercial success.
With global regulatory approvals including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, Shilpa Pharma is recognized for its strong quality systems, unmatched technical capabilities, and proven track record in regulated markets. Our advanced facilities specialize in oncology, high-potency APIs, complex generics, specialty therapeutics, biologics, and end-to-end formulation development—all backed by strict confidentiality and reliable supply performance.
Whether you are seeking cost-effective large-scale manufacturing, high-potency handling expertise, or a trusted CDMO partner for advanced formulations, Shilpa Pharma delivers solutions engineered for the German pharmaceutical market. We focus on precision, compliance, innovation, and on-time delivery, making us the preferred choice for companies looking for dependable CDMO services in Germany.
Partner with Shilpa Pharma—where world-class science meets world-class manufacturing to support Germany’s dynamic pharmaceutical and biotech landscape.

From simple to multi-step syntheses, we deliver precision-built CDMO solutions tailored to your needs.

Expertise in solid and solution-phase synthesis, cryogenic, and high-pressure reactions.

Offering non-GMP to GMP manufacturing — from lab-scale to commercial production.
Leading the Way in Pharma Innovation

Established

R&D workforce

Team size

Manufacturing site

Audits

Customers

Projects
At Shilpa Pharma, we are a trusted Global Contract Manufacturing Organization (CMO) delivering high-quality pharmaceutical manufacturing solutions to partners across Germany and Europe. With a strong foundation in India’s world-class manufacturing ecosystem, we combine cost efficiency with international standards to provide reliable, scalable, and compliant production services.
As a global CMO partner, Shilpa Pharma supports pharmaceutical companies at every stage — from formulation development and analytical testing to large-scale commercial manufacturing and packaging. Our facilities are built to meet cGMP, EMA, and WHO regulatory guidelines, ensuring consistent product quality and safety.
What truly sets us apart is our commitment to precision, transparency, and innovation. We understand the complexities of global pharmaceutical supply chains and provide seamless project management, timely delivery, and end-to-end documentation support. Partner with Shilpa Pharma — your trusted CMO partner in Germany, where scientific expertise meets global excellence.
At Shilpa Pharma, quality isn’t just a process — it’s a promise. We adhere to the highest international regulatory standards, ensuring that every product manufactured under our name meets the strictest benchmarks for safety, efficacy, and consistency. Our manufacturing facilities are fully compliant with cGMP, EMA, WHO, and USFDA guidelines, supported by rigorous internal audits and continuous improvement programs.
We maintain end-to-end traceability, validated systems, and robust quality control mechanisms throughout development, production, and packaging. From raw material sourcing to final product release, every stage is governed by precision, transparency, and accountability. This unwavering focus on compliance enables us to deliver products that not only meet regulatory expectations but also exceed client trust — making Shilpa Pharma a preferred CDMO partner in Germany and across the globe.
At Shilpa Pharma, we deliver world-class Contract Development and Manufacturing Organization (CDMO) services to pharmaceutical and biotechnology companies in Germany. As a trusted global CDMO partner, we help accelerate product development, ensure regulatory compliance, and optimize manufacturing efficiency. With our proven expertise in drug substance manufacturing, formulation development, and large-scale production, we bring your innovations to life with precision and reliability.
Whether you require end-to-end CDMO services in Germany or specialized CDMO biologics solutions, Shilpa Pharma offers flexible, scalable, and cost-effective options tailored to your specific development and commercial goals.
A Contract Development and Manufacturing Organization (CDMO) provides integrated drug development and manufacturing services to pharmaceutical and biotech firms. From formulation design and clinical trial material production to full-scale commercial manufacturing, CDMOs handle the complete product lifecycle. This partnership enables companies to focus on innovation, research, and patient care, while leveraging expert technical capabilities and global compliance support.
Global pharmaceutical firms partner with Shilpa Pharma for our seamless blend of Indian manufacturing excellence and European quality standards. Our reputation as a leading global CDMO is built on innovation, compliance, and client trust.
Here’s why companies in Germany choose Shilpa Pharma:
High-Quality Standards: We meet global regulatory norms including EU GMP, USFDA, and WHO compliance.
Cost Efficiency: Competitive pricing without compromising technology or product integrity.
Skilled Scientific Expertise: A dedicated team of experienced scientists, chemists, and engineers with global project experience.
Regulatory Strength: Proven track record with multiple international approvals and audits.
End-to-End Capabilities: From R&D and formulation to packaging and logistics — we cover it all under one roof.
Partnering with Shilpa Pharma for CDMO solutions delivers clear advantages:
Accelerated Time-to-Market: Streamlined development processes for faster launches.
Scalability: Flexible capacity for both small-batch and commercial-scale production.
Regulatory Expertise: In-depth understanding of EMA and global compliance standards.
Innovation & R&D Support: Access to advanced laboratories and formulation technologies.
Reduced Risk: Shared technical, operational, and compliance responsibility.
As a globally recognized CDMO in India, Shilpa Pharma’s manufacturing facilities meet the highest international quality standards. Our plants hold multiple global certifications and approvals that reflect our dedication to excellence and compliance.
Our facilities are:
USFDA Approved (United States Food & Drug Administration)
EU GMP Certified (European Union Good Manufacturing Practice)
ANVISA Approved (Brazilian Health Regulatory Agency)
COFEPRIS Approved (Mexico)
TGA Certified (Australia)
PMDA Approved (Japan)
KFDA Certified (South Korea)
These certifications position Shilpa Pharma as a trusted CDMO pharma company for both regulated and semi-regulated markets around the world.
Ranked among the top global CDMO companies, Shilpa Pharma is recognized for its innovation-driven approach, uncompromised quality, and transparent partnerships.
Our Key Strengths:
Comprehensive Expertise: From formulation to final product, we deliver complete CDMO solutions.
Advanced Infrastructure: Equipped with state-of-the-art technology and GMP-compliant facilities.
Global Reach: Serving pharmaceutical companies across Europe, Japan, China, and other markets.
Quality Commitment: Adherence to global compliance and best manufacturing practices.
Collaborative Partnership: We value transparency, flexibility, and on-time delivery.
Our commitment to excellence, reliability, and innovation has made Shilpa Pharma the preferred CDMO services provider for companies across Germany, Europe, Japan, and beyond. We take pride in our ability to bridge global standards with cost-effective, efficient solutions — helping clients achieve success in competitive pharmaceutical markets.
Get our capability overview via email